Prevalence and predictors of severe acute pancreatitis in patients with acquired immune deficiency syndrome (AIDS)

被引:0
作者
Manocha, AP
Sossenheimer, M
Martin, SP
Sherman, KE
Venkatesan, T
Whitcomb, DC
Ulrich, CD
机构
[1] Univ Cincinnati, Med Ctr, Dept Med, Div Digest Dis, Cincinnati, OH 45267 USA
[2] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: Recent case control data suggested that a severe course of acute pancreatitis in HIV+ patients was 1) common (50% of cases), 2) poorly predicted by Ranson's criteria (sensitivity 41%), and 3) accurately predicted by a diagnosis of AIDS (positive predictive value 67%). However, the definition of severity included length of stay in hospital and excluded commonly accepted markers (local complications, systemic complications, and need for surgery). The aim of this study was to determine 1) the prevalence of severity and 2) the value of these predictors with regard to severity, as defined by commonly accepted standardized criteria in patients with AIDS and acute pancreatitis. METHODS: A retrospective review identified 50 patients with AIDS exhibiting clinical, laboratory, and/or radiological features of acute pancreatitis. RESULTS: Only five patients followed a severe course as defined by accepted markers. Of these patients, 29 had values available for at least nine of 11 of Ranson's criteria (sensitivity 80%, specificity 54%). Points were awarded most commonly for decreased serum Ca2+ (n = 14) and elevated serum LDH (n = 7). CONCLUSIONS: In patients with AIDS and acute pancreatitis at our institutions, 1) the prevalence of severity and 2) the sensitivity of Ranson's criteria with regard to severity is comparable to that reported in large historical case series of immunocompetent patients. Pseudohypocalcemia and/or elevation in LDH are frequent, likely due to the catabolic infectious disease state. (Am J Gastroenterol 1999;94 : 784-789. (C) 1999 by Am. Coll. of Gastroenterology).
引用
收藏
页码:784 / 789
页数:6
相关论文
共 26 条
[1]  
BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586
[2]   PANCREATIC DISEASE IN AIDS - A REVIEW [J].
CAPPELL, MS ;
HASSAN, T .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1993, 17 (03) :254-263
[3]   ACUTE-PANCREATITIS IN HIV-SEROPOSITIVE PATIENTS - A CASE-CONTROL STUDY OF 44 PATIENTS [J].
CAPPELL, MS ;
MARKS, M .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 (03) :243-248
[4]   AIDS AND THE GUT [J].
CHUI, DW ;
OWEN, RL .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1994, 9 (03) :291-303
[5]  
Chukwuma C, 1996, E AFR MED J, V73, P72
[6]   2 AIDS PATIENTS WITH LIFE-THREATENING PANCREATITIS SUCCESSFULLY TREATED, ONE WITH GANCICLOVIR THE OTHER WITH FOSCARNET [J].
COLEBUNDERS, R ;
VANDENABBEELE, K ;
FLEERACKERS, Y ;
BOLS, K ;
LACHENAL, M ;
VANDAMME, L .
ACTA CLINICA BELGICA, 1994, 49 (05) :229-232
[7]  
Dowell S F, 1996, Tex Med, V92, P44
[8]  
GIMENEZ RAFD, 1992, MED CLIN-BARCELONA, V98, P339
[9]   ANALYSIS OF POTENTIAL RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PANCREATITIS IN PHASE-I PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX RECEIVING DIDANOSINE [J].
GRASELA, TH ;
WALAWANDER, CA ;
BELTANGADY, M ;
KNUPP, CA ;
MARTIN, RR ;
DUNKLE, LM ;
BARBHAIYA, RH ;
PITTMAN, KA ;
DOLIN, R ;
VALENTINE, FT ;
LIEBMAN, HA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06) :1250-1255
[10]  
HOFMAN P, 1994, GASTROEN CLIN BIOL, V18, P895